Bellevue Group AG

Q1 2020 13F-HR Detailed Holdings

Location
Kuesnacht, V8
Holdings as of
3/31/2020
Date filed
5/14/2020
Form type
13F-HR
Num holdings
239
Total value ($000)
$5,156,592
Net value change ($000)
-1,150,809 (-18.2%)
New positions
16
Sold out positions
17
Turnover %
2.1%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q4 2019
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
BDTX 33,184 NEW
FATE 33,099 2043.1%
MRNA 21,778 22.6%
GW PHARMACEUTICALS PLC 20,806 1776.8%
Molecular Templates, Inc. 20,562 113.5%
AMGN 16,947 174.2%
GILD 10,251 1857.1%
DXCM 10,119 58.9%
KZR 9,124 146.7%
HOLX 6,262 45.8%
Top Reduces (Value $000, Stocks/ETFs)
IONS -113,177 -22.2%
ESPR -110,982 -41.1%
NBIX -74,585 -20.9%
BMY -66,915 -49.9%
INCY -63,688 -20.7%
Sage Therapeutics, Inc. -53,758 -56.9%
Radius Health, Inc. -49,175 -35.1%
AGIO -48,852 -26.1%
INTERCEPT PHARMACEUTICALS, INC. -43,986 -49.6%
ALGN -42,444 -54.6%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 7 (0.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 BB Biotech AG 028-06964
2 Bellevue Asset Management AG 028-16892